Catalyst
Slingshot members are tracking this event:
Juno Therapeutics (JUNO) Suspends Phase 2 ROCKET Study Assessing JCAR015 in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 23, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Rocket, Jcar015, Relapsed/refractory, B Cell, Acute Lymphoblastic Leukemia
